No new info from what I heard on the podcast. Emphasis is mine.
Nothing about manufacturing or Lonza.
Things SI said that stood out
- ARDS trial total patient recruitment of about 300 expected to take in 3-4 months
- In the meantime we will have early interim analyses released that hopefully will show that the sort of efficacy in the pilot study will be replicated
- Number of trial readouts coming this year
- First product about to be launched for gvhd
- Hope the covid product will be the second
MSB - Most exciting 6 months, page-366
-
- There are more pages in this discussion • 364 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |